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Abstract
Background:  Mantle cell lymphoma (MCL) is an aggressive type of B-cell non-Hodgkin's
lymphoma that originates from small to medium sized lymphocytes located in the mantle zone of
the lymph node. Extra nodal involvement is present in the majority of cases, with a peculiar
tendency to invade the gastro-intestinal tract in the form of multiple lymphomatous polyposis. MCL
can be accurately diagnosed with the use of the highly specific marker Cyclin D1. Few cases of
mantle cell lymphoma presenting with intussuception have been reported. Here we present a rare
case of multiple intussusceptions caused by mantle cell lymphoma and review the literature of this
disease.
Case presentation: A 68-year-old male presented with pain, tenderness in the right lower
abdomen, associated with nausea and non-bilious vomiting. CT scan of abdomen revealed ileo-colic
intussusception. Laparoscopy confirmed multiple intussusceptions involving ileo-colic and ileo-ileal
segments of gastrointestinal tract. A laparoscopically assisted right hemicolectomy and extended
ileal resection was performed. Postoperative recovery was uneventful. The histology and immuno-
histochemistry of the excised small and large bowel revealed mantle cell lymphoma with multiple
lymphomatous polyposis and positivity to Cyclin D1 marker. The patient was successfully treated
with Rituximab-CHOP chemotherapy and remains in complete remission at one-year follow-up.
Conclusion: This is a rare case of intestinal lymphomatous polyposis due to mantle cell lymphoma
presenting with multiple small bowel intussusceptions. Our case highlights laparoscopic-assisted
bowel resection as a potential and feasible option in the multi-disciplinary treatment of mantle cell
lymphoma.
Background
Approximately 6% of lymphomas are classified as mantle
cell lymphomas (MCL) [1,2]. MCL generally occurs in
adults with a median age of 60 and a male predominance.
Advanced disease with involvement of regional lymph
nodes, liver, spleen, or peripheral blood is common at
presentation. More than 50% of patients with MCL have
bone marrow involvement at the time of diagnosis. The
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primary presentation of extra nodal disease occurs in one
quarter of patients and frequently involves Waldeyer's
ring and the gastrointestinal tract. Multiple lymphoma-
tous polyposis (MLP) is one of the most common primary
gastrointestinal presentations of MCL and accounts for
approximately about 9% of primary gastrointestinal lym-
phomas [3].
MLP most commonly occurs in the ascending colon and
the small bowel, particularly in the ileum and ileocecal
region. Occasionally, however, numerous polyps are
present throughout the entire gastrointestinal tract. Pol-
yps may be sessile, polypoid or both. They range in size
from 0.1 to 4–5 cm and present with ulceration.
Intussusception occurs when a proximal segment of
bowel (intussusceptum) telescopes into the lumen of an
adjacent distal segment (intussuscipiens) and can occur
anywhere within the gastrointestinal tract. Although fairly
common in children, adult intussusception is relatively
rare representing only 1% of patients with bowel obstruc-
tions [4,5]. We present a case of multiple lymphomaotous
polyposis due to mantle cell lymphoma presenting with
multiple intussusceptions.
Case presentation
A 68-year-old previously healthy male presented with four
days of constant pain in the right lower abdomen, associ-
ated with nausea and vomiting. There was no history of
fever or weight loss. Physical examination revealed nor-
mal vital signs, a soft distended abdomen with hyperac-
tive bowel sounds, and a palpable tender mass in the right
lower quadrant. Digital rectal examination revealed hem-
orrhoids and guaiac positive stool. Laboratory evaluation
was notable for low hematocrit (31%) and albumin (2.6
g/dL) levels. A plain abdominal radiograph showed a
nonspecific gas pattern in the bowel with fecal loading of
the descending and sigmoid colon.
A CT-scan of the abdomen with contrast showed ileo-colic
intussusception (Fig 1). At laparoscopy, ileocecal intus-
susception and two more ileo-ileal intussusceptions were
found along with multiple tumors involving the entire
length of jejunum, ileum and ascending colon (Figures 2,
3, 4).
The patient underwent a laparoscopically-assisted right
hemicolectomy, with extended ileal resection and a sta-
pled ileo-colic anastomosis. The postoperative period was
uneventful and the patient was discharged on the fourth
postoperative day.
The pathology confirmed multiple lesions of about one
inch diameter, involving the small bowel, cecum, and
asceding colon (Fig 5). Histology revealed a malignant B-
cell lymphoma. Immuno histochemistry and immu-
nophenotypic analyses were positive for Cyclin D1 (Fig
6), CD20 (Fig 7), CD5 (Fig 8) and CD 79a (Fig 9), but
negative for BCL6, CD23 and CD10, thus confirming the
diagnosis of mantle cell lymphoma (Fig 10).
Upon hospital discharge, the patient underwent staging
investigations with negative bone marrow involvement.
He received 6 out of 8 planned cycles of chemotherapy
with rituximab-CHOP (cyclophosphamide, doxorubicin,
vincristine, prednisone) with moderate to severe toxicity
in form of fatigue, febrile neutropenia despite growth fac-
tors and dose reduction, and failure to thrive. Restaging
with PET CT confirmed complete response with no resid-
CT scan of abdomen showing ileo-colic intussusception Figure 1
CT scan of abdomen showing ileo-colic intussuscep-
tion.
Intraoperative pictures showing multiple (three) intussuscep- tions (part 1) Figure 2
Intraoperative pictures showing multiple (three) 
intussusceptions (part 1).World Journal of Surgical Oncology 2009, 7:60 http://www.wjso.com/content/7/1/60
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ual disease. At one year follow-up, he remains in remis-
sion with a good performance status.
Discussion
The term "multiple lymphomatous polyposis" was first
presented by Cornes in 1961 to describe numerous poly-
poid lesions throughout the entire GI tract consisting of
mucosal involvement by malignant lymphoma [3]. In
1980, Blackshaw classified MLP as B-cell centrocytic non-
Hodgkin's lymphoma according to the Kiel classification
[6,7] According to the Working Formulation; MLP is clas-
sified as a diffuse, small-cleaved cell malignant lym-
phoma [8]. Isaacson et al. [9] and Triozzi et al. [10] have
suggested that MLP is the digestive counterpart of mantle
zone lymphoma that arises in lymph nodes. Following
further immunohistochemical and cytogenetic study,
MLP has been confrmed to be a mantle cell lymphoma
involving the gastrointestinal tract [10].
MLP can present with symptoms such as abdominal pain,
diarrhea, bleeding, and less frequently, protein-losing
enteropathy, intestinal malabsorption, or chylous ascites.
Rarely, MLP presents as an acute abdomen due to perfora-
tion or intestinal obstruction. MLP polyps usually occur in
the ileocecal region and in one third of cases present as a
mass [11,12]. Upper gastrointestinal endoscopy, enteros-
copy and colonoscopy are important tools in diagnosing
MLP to assess the locations of the polyps and obtain tissue
biopsies. Differentiating lymphomatous polyposis from
Intraoperative pictures showing multiple (three) intussuscep- tions (part 2) Figure 3
Intraoperative pictures showing multiple (three) 
intussusceptions (part 2).
Intraoperative pictures showing multiple (three) intussuscep- tions (part 3) Figure 4
Intraoperative pictures showing multiple (three) 
intussusceptions (part 3).
Excised specimen showing numerous intraluminal and serosal  lymphomatous polyposis Figure 5
Excised specimen showing numerous intraluminal 
and serosal lymphomatous polyposis.
Immunohistochemistry of the polypoid lesion revealing  strong positivity with Cyclin D1 Figure 6
Immunohistochemistry of the polypoid lesion reveal-
ing strong positivity with Cyclin D1.World Journal of Surgical Oncology 2009, 7:60 http://www.wjso.com/content/7/1/60
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adenomatous or hamartomatous polyposis by endo-
scopic or radiological evaluation alone is impossible and
tissue diagnosis is required. Additionally, not all lympho-
matous polyposis of the gastrointestinal tract result from
MCL. Michopulos et al, showed that only 12 out of 35
cases of lymphomatous polyposis were MCL [13]. Follic-
ular lymphoma and MALT lymphoma can also present
with MLP.
Definitive diagnosis of MLP requires histological exami-
nation of the specimen with histomorphologic and
immunophenotypic analysis. In our case, histological
examination of the ileum, colon, mesenteric mass, and
lymph nodes showed malignant B-cell non-Hodgkin's
lymphoma. The histo morphology and the immunophe-
notypic analysis were consistent with a mantle cell lym-
phoma – positive for Cyclin D1, CD20, CD79a and CD5;
negative for BCL16, CD23 and CD10. These immunomar-
kers are essential in distinguishing mantle cell from other
types of lymphoma. See table 1[14].
Additionally, cytogenetic analysis of MCL shows rear-
rangement of the bcl-1 locus on chromosome11 due to t
(11:14) (q13:q32) translocation, accompanied by cyclin
D1 antigen overexpression [15].
Immunohistochemical stain with CD 20 showing strong posi- tivity Figure 7
Immunohistochemical stain with CD 20 showing 
strong positivity.
Immuno histochemical stain with CD5 showing strong reac- tivity Figure 8
Immuno histochemical stain with CD5 showing 
strong reactivity.
Immuno histochemical stain with CD79a showing strong  positivity Figure 9
Immuno histochemical stain with CD79a showing 
strong positivity.
Cytological appearance of mantle cell lymphoma High power  field Figure 10
Cytological appearance of mantle cell lymphoma 
High power field. The tumor is composed of small to 
medium sized lymphocytes.World Journal of Surgical Oncology 2009, 7:60 http://www.wjso.com/content/7/1/60
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Surgery is the mainstay of therapy for intussusception in
adult patients. Increasingly, laparoscopy is replacing open
operations as the preferred approach. Diagnostic laparos-
copy may assist in the diagnosis of intussusception in
cases where diagnosis is suspected but not confirmed by
preoperative workup [16]. If the diagnosis is confirmed,
then appropriate surgical therapy and resection can be
performed depending on the comfort level of the surgeon.
Laparoscopy may aid in planning the incision if a laparo-
scopic-assisted or even laparotomy incision is required.
MCLs usually respond poorly to conventional therapeutic
regimens and are associated with short median survival.
Current combinations of monoclonal antibodies and
multi-agent chemotherapy have achieved significant
improvement in MCL response rates. Overall response
rates range from 80% to 95% and complete response rates
of 30% to 50% are frequently being achieved [17]. The R-
CHOP regimen was chosen due to the patient's poor per-
formance status at the time of diagnosis. Our patient only
received 6 out of 8 planned cycles of R-CHOP due to tox-
icity. Other chemotherapy regimens such as R-Hyper-
CVAD (Rituxan with hyperfractionated cyclophospha-
mide, vincristine, doxorubicin, and dexamethasone alter-
nating with high-dose methotrexate and cytarabine) have
shown good results in uncontrolled trials. However, it is a
more aggressive regimen associated with increased toxic-
ity. Despite the improved high response rate, current over-
all survival rates remain poor because of the early relapse.
Median survival with standard treatment for MCL patients
remains between 3 and 4 years [18]. Intensive immuno-
chemotherapy both with and without stem cell support
has been successfully used to prolong the progression-free
survival to 5 or more years [19,20]. These approaches
along with other innovative strategies utilizing bortezem-
bin [21], temsirolimus [22] or radioimmuno conjugates
for the relapsed or refractory setting remain under active
investigation.
To our knowledge, this is the first reported case of MCL
presenting with multiple intussusceptions of gastrointes-
tinal tract, separately involving the ileo colic and ileo-ileal
segments. Our case highlights laparoscopic-assisted bowel
resection as a potential and feasible option in the multi-
disciplinary treatment of mantle cell lymphoma, when
intussusception from MLP occurs.
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